Search

everythinglearnresearchcommunity

for

Search:↓

The new test can measure very small amounts of testosterone in hair, and grinding the hair up first gives more accurate results.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Patients with alopecia areata have lower RBC folate levels, especially in severe cases.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Testing for various autoantibodies in Indian children with lupus can help predict disease symptoms and risks.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

A 15-year-old girl with hypothyroidism had excess hair and skin issues due to blocked hair follicles.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Thyroid hormone therapy effectively treated the man's rare muscle and heart issues.

SII is a useful and affordable tool to assess and monitor alopecia areata.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Keratin 14 may be an autoantigen in autoimmune skin diseases.

Inhibiting TYK2 can restore hair growth in alopecia areata.

The woman's facial symptoms are best explained by primary Sjögren’s Syndrome.

Children with frequent severe infections and low antibodies should be checked for immune deficiencies.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.